Antipsychotic drug use in neurodegenerative disease in the elderly: problems and potential from a pharmacological perspective

Author： Reynolds G.P.  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.4, 2001-04, pp. : 543-548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Problems with Medication Use in the Elderly: An Australian Perspective

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 36, Iss. 1, 2006-03 ,pp. : 58-66

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of Antipsychotic Drug Use in Patients with Alzheimer’s Disease Treated with Rivastigmine

By Suh D-C.  

Drugs & Aging, Vol. 21, Iss. 6, 2004-01 ,pp. : 395-403

Adis International

Access to resources Recommend Favorite

Antipsychotic use is suboptimal in elderly dementia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 585, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Hypothermia following antipsychotic drug use

By Marum Rob   Wegewijs Michelle   Loonen Anton   Beers Erna  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 6, 2007-06 ,pp. : 627-631

Springer Publishing Company

Access to resources Recommend Favorite

Novel Drug Delivery Systems for Insulin: Clinical Potential for Use in the Elderly

By Belmin J.  

Drugs & Aging, Vol. 20, Iss. 4, 2003-01 ,pp. : 303-312

Adis International

Access to resources Recommend Favorite